Swedish Pharmacy Sales Rose in 2025 as Weight-Loss Drug Demand Grew
Photo: JoNel Aleccia/AP/TT

Swedish Pharmacy Sales Rose in 2025 as Weight-Loss Drug Demand Grew

Pharmacy sales increased in 2025, according to a report from the Dental and Pharmaceutical Benefits Agency (TLV). Growth is particularly strong in weight-loss drugs.

Advertisement

“The strong growth in e-commerce and in product segments outside the pharmaceutical benefits system is affecting market dynamics, and TLV is monitoring developments closely,” says Harald Ström, head of unit at TLV, in a press release.

Pharmacy sales amounted to SEK 71 billion last year and are expected to continue rising in the coming years. By 2028, sales are expected to reach around SEK 83 billion.

“Prescription drugs outside the pharmaceutical benefits system, including drugs for obesity, are particularly expected to continue growing rapidly,” the report states.

TLV has repeatedly rejected requests to include weight-loss drugs such as Wegovy, made by the Danish company Novo, in the benefits system.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All